BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers.
Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers.
Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 319 N Bernardo Ave, Mountain View,california 94043,united States
- Phone
- (408)809-1030
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioeclipse.com
- Keywords
- oncology, immuno-therapy, cancer, biotech, start-up.
- HQ
- Mountain View, California
Bioeclipse Therapeutics, Inc Questions
Bioeclipse Therapeutics, Inc's helpline number is (408)809-1030
Bioeclipse Therapeutics, Inc's website is bioeclipse.com
Bioeclipse Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/bioeclipse-therapeutics-inc
Bioeclipse Therapeutics, Inc has
6 employees.
View email and phone details for 6
employees at Bioeclipse Therapeutics, Inc.
Bioeclipse Therapeutics, Inc's industry is
Biotechnology Research
Bioeclipse Therapeutics, Inc's top competitors are
Teon Therapeutics Inc.,
Tradewind Bioscience,
Altay Therapeutics,
Alessa Therapeutics, Inc.,
Maze Therapeutics,
Aspa Therapeutics,
Bacstitch Dna,
Biovaxys Technology Corp.,
Acurex Biosciences,
Spruce Biosciences.
Bioeclipse Therapeutics, Inc's support email address is info@concentrxbio.com
Bioeclipse Therapeutics, Inc's categories are Biotechnology Research
Bioeclipse Therapeutics, Inc's founding year is 2017
